Overview

A Study to Learn How Different Amounts of the Study Medicine Danuglipron Are Taken up Into the Blood in Otherwise Healthy Adults With Overweight or Obesity

Status:
COMPLETED

Trial end date:
2024-12-18

Target enrollment:

Participant gender:

Summary

The purpose of this study is to learn the following about the study medicine, danuglipron, after multiple days of dosing in healthy adults who are overweight or obese: * how the study medicine, danuglipron, is taken up into the blood * about the safety and tolerability of danuglipron The total number of weeks of the study is about 15 (about 4 months).

Phase:

PHASE1

Details

Lead Sponsor:

Pfizer

Treatments:

danuglipron